Evidence map›Paper›PMID 23733888›Full record

ArticleG3 (Bethesda, Md.)2013

Targeting of Painting of fourth to roX1 and roX2 proximal sites suggests evolutionary links between dosage compensation and the regulation of the fourth chromosome in Drosophila melanogaster.

Lina E Lundberg, Maria Kim, Anna-Mia Johansson, Marie-Line Faucillion, Rafael Josupeit, Jan Larsson

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TheGenetics · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lina E LundbergDepartment of Molecular Biology, Umeå University, SE-90187 Umeå, Sweden.
Maria Kim
Anna-Mia Johansson
Marie-Line Faucillion
Rafael Josupeit
Jan Larsson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Drosophila melanogaster, two chromosome-specific targeting and regulatory systems have been described. The male-specific lethal (MSL) complex supports dosage compensation by stimulating gene expression from the male X-chromosome, and the protein Painting of fourth (POF) specifically targets and stimulates expression from the heterochromatic 4(th) chromosome. The targeting sites of both systems are well characterized, but the principles underlying the targeting mechanisms have remained elusive. Here we present an original observation, namely that POF specifically targets two loci on the X-chromosome, PoX1 and PoX2 (POF-on-X). PoX1 and PoX2 are located close to the roX1 and roX2 genes, which encode noncoding RNAs important for the correct targeting and spreading of the MSL-complex. We also found that the targeting of POF to PoX1 and PoX2 is largely dependent on roX expression and identified a high-affinity target region that ectopically recruits POF. The results presented support a model linking the MSL-complex to POF and dosage compensation to regulation of heterochromatin.

Indexed as

AnimalsAnimals, Genetically ModifiedBiological EvolutionChromosomal Proteins, Non-HistoneChromosomesDosage Compensation, GeneticDrosophila melanogasterDrosophila ProteinsFemaleGene ExpressionGenetic LociHeterochromatinMaleNuclear ProteinsProtein BindingRNA-Binding ProteinsChromosomal Proteins, Non-HistoneDrosophila ProteinsHeterochromatinmsl-1 protein, DrosophilaNuclear ProteinsPabp2 protein, DrosophilaPof protein, DrosophilaRNA-Binding ProteinsRNA, UntranslatedroX1 protein, DrosophilaTranscription Factorsdosage compensationDrosophila melanogasterepigeneticsheterochromatinPainting of fourth

Identifiers

PMID23733888
PMCPMC3737172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.